2-BenzylaminopyridineCAS# 6935-27-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6935-27-9 | SDF | Download SDF |
PubChem ID | 23362 | Appearance | Powder |
Formula | C12H12N2 | M.Wt | 184 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | N-benzylpyridin-2-amine | ||
SMILES | C1=CC=C(C=C1)CNC2=CC=CC=N2 | ||
Standard InChIKey | WYHXNQXDQQMTQI-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H12N2/c1-2-6-11(7-3-1)10-14-12-8-4-5-9-13-12/h1-9H,10H2,(H,13,14) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Benzylaminopyridine Dilution Calculator
2-Benzylaminopyridine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.4348 mL | 27.1739 mL | 54.3478 mL | 108.6957 mL | 135.8696 mL |
5 mM | 1.087 mL | 5.4348 mL | 10.8696 mL | 21.7391 mL | 27.1739 mL |
10 mM | 0.5435 mL | 2.7174 mL | 5.4348 mL | 10.8696 mL | 13.587 mL |
50 mM | 0.1087 mL | 0.5435 mL | 1.087 mL | 2.1739 mL | 2.7174 mL |
100 mM | 0.0543 mL | 0.2717 mL | 0.5435 mL | 1.087 mL | 1.3587 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- CPPHA
Catalog No.:BCC1501
CAS No.:693288-97-0
- CYC116
Catalog No.:BCC2181
CAS No.:693228-63-6
- H-Ile-OtBu.HCl
Catalog No.:BCC2965
CAS No.:69320-89-4
- (R)-baclofen
Catalog No.:BCC4503
CAS No.:69308-37-8
- 12-Aminolauric acid
Catalog No.:BCC8436
CAS No.:693-57-2
- 3-beta-O-(cis-p-Coumaroyl)maslinic acid
Catalog No.:BCN1375
CAS No.:69297-40-1
- 8-O-Acetylharpagide
Catalog No.:BCN4256
CAS No.:6926-14-3
- Harpagide
Catalog No.:BCN4996
CAS No.:6926-08-5
- N-Benzylcinchonidinium chloride
Catalog No.:BCC9094
CAS No.:69257-04-1
- 1,2,3-Tri-O-methyl-7,8-methyleneflavellagic acid
Catalog No.:BCN7205
CAS No.:69251-99-6
- Pinoresinol 4-O-beta-D-glucopyranoside
Catalog No.:BCN1376
CAS No.:69251-96-3
- Osthol hydrate
Catalog No.:BCN1377
CAS No.:69219-24-5
- Obtucarbamate A
Catalog No.:BCN3936
CAS No.:6935-99-5
- Galanthamine hydrochloride
Catalog No.:BCC8277
CAS No.:5072-47-9
- Boc-D-Thr(Bzl)-OH
Catalog No.:BCC3454
CAS No.:69355-99-3
- Pendulone
Catalog No.:BCN8248
CAS No.:69359-09-7
- Schisanhenol
Catalog No.:BCN2508
CAS No.:69363-14-0
- Sulbactam sodium
Catalog No.:BCC4852
CAS No.:69388-84-7
- Lappaol H
Catalog No.:BCN8415
CAS No.:69394-18-9
- Amonafide
Catalog No.:BCC1249
CAS No.:69408-81-7
- SB505124
Catalog No.:BCC5087
CAS No.:694433-59-5
- 17-PA
Catalog No.:BCC7452
CAS No.:694438-95-4
- Parvifuran
Catalog No.:BCN7780
CAS No.:69470-93-5
- 2-Methyl-4-isobutyrylphloroglucinol
Catalog No.:BCN7176
CAS No.:69480-03-1
N-depyridination and N-dedimethylaminoethylation of tripelennamine and pyrilamine in the rat. New metabolic pathways.[Pubmed:1976067]
Drug Metab Dispos. 1990 Jul-Aug;18(4):453-61.
N-(2-Dimethylaminoethyl)benzylamine and 2-Benzylaminopyridine were identified as two new urinary metabolites of tripelennamine in the rat by GC/MS. 2-(4-Methoxybenzylamino)-pyridine and N-(dimethylaminoethyl)-4-hydroxybenzylamine were identified as new urinary metabolites of pyrilamine by GC/MS. Thus, in addition to N- and O-demethylation, hydroxylation, and glucuronidation, N-debenzylation, N-depyridination and N-dedimethylaminoethylation were shown to be novel pathways for metabolism of tripelennamine and pyrilamine. The mechanism for N-depyridination and N-dealkylation is discussed.